Description: Genfit is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology.
Home Page: www.genfit.com
Parc EurasantE
Loos,
59120
France
Phone:
33 3 20 16 40 00
Officers
| Name | Title |
|---|---|
| Mr. Jean-Francois Mouney | Co-Founder & Chairman |
| Mr. M. Pascal Prigent | Chief Exec. Officer |
| Prof. Bart Staels | Co-Founder & Chairman of the Scientific Advisory Board |
| Mr. Thomas Baetz | Chief Financial Officer |
| Mr. Pascal Caisey | Chief Operating Officer |
| Dr. Dean W. Hum Ph.D. | Chief Scientific Officer |
| Mr. Laurent Lannoo | Corp. Sec. & Director of Legal Affairs |
| Ms. Stefanie Magner | Chief Compliance Officer & VP of International Legal Affairs |
| Ms. Emilie Desodt | Vice-Pres of HR |
| Mr. Jean-Christophe Marcoux | Chief Strategy Officer |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 4.1462 |
| Price-to-Book MRQ: | 1.3586 |
| Price-to-Sales TTM: | 1.8652 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 134 |